• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 2 of 38
Brainstorm Health 2021-Pfizer-Albert Bourla
Newsletters
Pfizer CEO Albert Bourla sees ‘a scientific renaissance’ in the U.S. amid backdrop of political threats to the future of research
By Diane BradyApril 24, 2025
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
Commentary
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
By Jeffrey Sonnenfeld and Steven TianFebruary 5, 2025
Albert Bourla, chief executive officer of Pfizer Inc., during a panel session at the World Economic Forum
Health
Pfizer CEO had dinner with RFK Jr.: ‘I’m cautiously optimistic’ in spite of his history with vaccines
By Hallie SteinerFebruary 4, 2025
Row of medical vials and syringe
Health
Pfizer’s Covid boost overshadowed by Kennedy threat to vaccines
By Bloomberg and Damian GardeFebruary 4, 2025
Days before President Donald Trump took office a second time, the Department of Health and Human Services granted Moderna $590 million for the development of mRNA vaccines for bird flu and other influenza viruses.
Health
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
By Lindsey LeakeJanuary 22, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By Lindsey LeakeJanuary 21, 2025
A white sign featuring the Pfizer logo
Health
GSK, Pfizer RSV shots must warn about rare paralysis risk
By BloombergJanuary 8, 2025
Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1
Health
Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1
By Jennifer FieldsJanuary 3, 2025
As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
Commentary
As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
By Jeffrey Sonnenfeld and Steven TianOctober 24, 2024
Just 25% of people at high risk of pneumococcal disease—children younger than 2, adults older than 64, and those with certain chronic health conditions such as diabetes—have been immunized, according to an August 2024 survey by the National Foundation for Infectious Diseases.
Health
Pneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccination
By Lindsey LeakeOctober 22, 2024
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
Commentary
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
By Jeffrey Sonnenfeld and Steven TianOctober 10, 2024
Albert Bourla puts his palm flat on tup of his other hand, rolled up in a fist, as he sits and listens to a question onstage at a conference.
Finance
Pfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs
By Greg McKennaOctober 7, 2024
As of spring 2024, at which time two RSV vaccines had been FDA-approved, less than 25% of eligible U.S. adults 60 and older had gotten one, according to the CDC.
Health
RSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine
By Lindsey LeakeOctober 4, 2024
About 47% of U.S. adults aged 50 and older said they were very or somewhat unlikely to get the new 2024–25 COVID-19 vaccine, according the University of Michigan’s National Poll on Healthy Aging.
Health
COVID sickens older adults most severely, but less than half say they’ll get the new vaccine
By Lindsey LeakeSeptember 30, 2024
As of March 2024, the Centers for Disease Control and Prevention no longer advises a five-day isolation period when you test positive for COVID-19, but recommends taking other precautions once your symptoms subside.
Health
Got COVID? Here are the new 2024 isolation guidelines
By Lindsey LeakeSeptember 27, 2024
1
  • 1
  • 2
  • 3
  • 4
  • 5
...38
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimisticplaceholder alt text
By Jason MaJuly 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.